Together, these data confirm that the role of IRF8 mutations is recognized principally in vivo, furthering the concept that immune escape, rather than a lymphoma cell intrinsic effect, is at the core of IRF8 dysfunction in B cell lymphomas. Here, IRF8 is linked to lymphoma.